MARGARET WILLIAMS: Open Payments
NPI 1831553585 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,172 in 91 payments from 35 companies in 2025. Trend: 2023 $1,840 · 2024 $3,526 · 2025 $3,172
Food & beverage: $2,698Long term medical supply or device loan: $283Education: $191
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 17 | $522 |
| AstraZeneca Pharmaceuticals LP | 12 | $385 |
| Janssen Biotech, Inc. | 7 | $270 |
| GlaxoSmithKline, LLC. | 3 | $226 |
| Merck Sharp & Dohme LLC | 6 | $192 |
| SEAGEN INC. | 2 | $191 |
| Genmab U.S., Inc. | 2 | $145 |
| GENZYME CORPORATION | 2 | $126 |
| BeOne Medicines USA, Inc. | 3 | $94 |
| Eisai Inc. | 3 | $81 |
Products named: KISQALI, RYBREVANT, KEYTRUDA, Epkinly, WAYRILZ, ZEJULA, IMFINZI, Lenvima.
Industry payments across MD — which companies pay providers there.
